Literature DB >> 21773687

Community-Acquired Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections: Management and Prevention.

Luke F Chen1, Cody Chastain, Deverick J Anderson.   

Abstract

Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) was a rare phenomenon until the past decade; now CA-MRSA is endemic in many communities and is the most common cause of skin and soft tissue infections presenting to emergency rooms. CA-MRSA is distinct from its hospital-acquired counterpart, and has caused devastating infections in many healthy individuals. The epidemiology of CA-MRSA continues to evolve, and the challenge is to use the most appropriate and effective therapeutic and preventative strategies against this pathogen. This article reviews the current epidemiology of CA-MRSA, its definitions, and common clinical manifestations in the community. The article also summarizes current therapeutic options for CA-MRSA as well as strategies to reduce the transmission and the impact of CA-MRSA in both community and health care settings.

Entities:  

Year:  2011        PMID: 21773687     DOI: 10.1007/s11908-011-0198-4

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  48 in total

Review 1.  Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy.

Authors:  Kyra Chua; Frederic Laurent; Geoffrey Coombs; M Lindsay Grayson; Benjamin P Howden
Journal:  Clin Infect Dis       Date:  2011-01-01       Impact factor: 9.079

2.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

3.  Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia.

Authors:  E E Udo; J W Pearman; W B Grubb
Journal:  J Hosp Infect       Date:  1993-10       Impact factor: 3.926

4.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

Authors:  Catherine Liu; Arnold Bayer; Sara E Cosgrove; Robert S Daum; Scott K Fridkin; Rachel J Gorwitz; Sheldon L Kaplan; Adolf W Karchmer; Donald P Levine; Barbara E Murray; Michael J Rybak; David A Talan; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2011-02-01       Impact factor: 9.079

5.  Room decontamination with UV radiation.

Authors:  William A Rutala; Maria F Gergen; David J Weber
Journal:  Infect Control Hosp Epidemiol       Date:  2010-10       Impact factor: 3.254

6.  Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.

Authors:  Mark H Wilcox; Kenneth J Tack; Emilio Bouza; Daniel L Herr; Bernhard R Ruf; M Marian Ijzerman; Rodney V Croos-Dabrera; Mark J Kunkel; Charles Knirsch
Journal:  Clin Infect Dis       Date:  2009-01-15       Impact factor: 9.079

7.  Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men.

Authors:  Binh An Diep; Henry F Chambers; Christopher J Graber; John D Szumowski; Loren G Miller; Linda L Han; Jason H Chen; Felice Lin; Jessica Lin; Tiffany HaiVan Phan; Heather A Carleton; Linda K McDougal; Fred C Tenover; Daniel E Cohen; Kenneth H Mayer; George F Sensabaugh; Françoise Perdreau-Remington
Journal:  Ann Intern Med       Date:  2008-01-30       Impact factor: 25.391

8.  Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms.

Authors:  Martin E Stryjewski; Donald R Graham; Samuel E Wilson; William O'Riordan; David Young; Arnold Lentnek; Douglas P Ross; Vance G Fowler; Alan Hopkins; H David Friedland; Steven L Barriere; Michael M Kitt; G Ralph Corey
Journal:  Clin Infect Dis       Date:  2008-06-01       Impact factor: 9.079

Review 9.  Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection.

Authors:  Loren G Miller; Binh An Diep
Journal:  Clin Infect Dis       Date:  2008-03-01       Impact factor: 9.079

10.  Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in the community pediatric population.

Authors:  Mari M Nakamura; Kasey L Rohling; Michael Shashaty; Hongzhou Lu; Yi-Wei Tang; Kathryn M Edwards
Journal:  Pediatr Infect Dis J       Date:  2002-10       Impact factor: 2.129

View more
  2 in total

1.  Oral Antimicrobial Therapy: Efficacy and Safety for Methicillin-Resistant Staphylococcus aureus Infections and Its Impact on the Length of Hospital Stay.

Authors:  Young Kyung Yoon; Eu Suk Kim; Jian Hur; Shinwon Lee; Shin Woo Kim; Jin Won Cheong; Eun Ju Choo; Hong Bin Kim
Journal:  Infect Chemother       Date:  2014-09-24

2.  Intrawound vancomycin in primary hip and knee arthroplasty: a safe and cost-effective means to decrease early periprosthetic joint infection.

Authors:  Nick N Patel; George N Guild; Arun R Kumar
Journal:  Arthroplast Today       Date:  2018-09-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.